Last reviewed · How we verify
Placebo toxin
Placebo toxin is a Small molecule drug developed by University Hospital, Toulouse. It is currently FDA-approved. Also known as: placebo injection.
Placebo toxin is a non-active control substance used in clinical trials to establish baseline efficacy and safety comparisons.
Placebo toxin is a type of intervention used in clinical trials to compare the effects of a real treatment, such as onabotulinumtoxinA, in studies for conditions like temporomandibular joint disorders and cerebral palsy. The placebo toxin is used as a control group in these studies to determine the efficacy of the actual treatment being tested.
At a glance
| Generic name | Placebo toxin |
|---|---|
| Also known as | placebo injection |
| Sponsor | University Hospital, Toulouse |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a placebo, this agent contains no active pharmaceutical ingredient and serves as a control arm in clinical studies. It is used to measure the placebo effect and distinguish true drug efficacy from psychological or natural disease progression effects. The term 'toxin' in the name is unusual and may reflect historical nomenclature or a specific formulation context at the institution.
Approved indications
Common side effects
Key clinical trials
- Effects of Bronchial Segmental Endotoxin Instillation in Humans (PHASE2)
- Inflammatory Challenge in Human Aggression. (PHASE2)
- Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
- IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction (PHASE2)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine (PHASE3)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine (PHASE3)
- Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PHASE3)
- Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo toxin CI brief — competitive landscape report
- Placebo toxin updates RSS · CI watch RSS
- University Hospital, Toulouse portfolio CI
Frequently asked questions about Placebo toxin
What is Placebo toxin?
How does Placebo toxin work?
Who makes Placebo toxin?
Is Placebo toxin also known as anything else?
What development phase is Placebo toxin in?
Related
- Manufacturer: University Hospital, Toulouse — full pipeline
- Also known as: placebo injection
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing